# FDA Inspection 866571 - Ohio State University Medical Center - February 20, 2014

Source: https://www.keypedia.com/records/fda_inspections/ohio-state-university-medical-center/09c5a7ef-91f1-48f4-aaad-fa0ff9514d63
Source feed: FDA_Inspections

> FDA Inspection 866571 for Ohio State University Medical Center on February 20, 2014. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 866571
- Company Name: Ohio State University Medical Center
- Inspection Date: 2014-02-20
- Classification: No Action Indicated (NAI)
- Project Area: Human Cellular, Tissue, and Gene Therapies
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 718014 - 2011-03-14](https://www.keypedia.com/records/fda_inspections/ohio-state-university-medical-center/1ac9be28-7b0a-4aa8-b76c-45467d09165f)
- [FDA Inspection 702528 - 2010-12-17](https://www.keypedia.com/records/fda_inspections/ohio-state-university-medical-center/34c5b970-8443-444a-a3e7-ff9151635c26)

Company: https://www.keypedia.com/companies/ohio-state-university-medical-center/e231d9e7-7430-4d7c-9577-6bfa2a7cf832

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d